Accueil / Formation Recherche / Publications / Publications Angoiedèmes à kinines

Publications Angoiedèmes à kinines

Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.

Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.

Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: Three additional French families. 

Hereditary Angioedema, Clinical Presentation and Socio-Economic Cost of 200 French Patients. 

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.


Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight : findings from the Icatibant Outcome Survey, a cohort observational study. Caballero T et al. Clin Transl Allergy. 2018 Mar 23.
 
Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial. Javaud N et al. Ann Emerg Med. 2018 Mar.
 
Icatibant for ACE-inhibitor angioedema, an opportunity to treat the patients ? Javaud N et al. J Allergy Clin Immunol Pract. 2017 Nov - Dec.

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey. Aberer W et al. Allergy Asthma Clin Immunol. 2017 Jul 5;13:3.

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. Caballero T et al. J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1214-1222.

Normal PAI-2 level in French FXII-HAE patients. Marlu R et al. J Allergy Clin Immunol. 2017 May;139(5):1719-1720.

Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort. Bouillet L et al. Eur J Dermatol. 2017 Apr 1;27(2):155-159.

ACTUALITÉS

Le Pr Eric Oksenhendler récompensé "Médecin de l'année 2018" pour son travail sur la maladie de Castleman

Calendrier 2019 de la filière MaRIH disponible !
Téléchargez le nouveau calendrier avec les dates de la filière, des centres de référence, des associations de patients et des sociétés savantes
Nouveau cas clinique "Amylose AL"
Testez vos connaissances
Voir toutes les actualités